                         SEQUENCE LISTING

<110>  INSERM
 
<120>  USE OF INHIBITORS OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE FOR 
       THE TREATMENT OF CARDIOMETABOLIC DISEASES

<130>  BIO18299 BELLIEN

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  single domain antibody FR1

<400>  1

Val Gln Leu Gln Ala Ser Gly Gly Gly Phe Val Gln Pro Gly Gly Ser 
1               5                   10                  15      


Leu Arg Leu Ser Cys Ala Ala Ser Gly 
            20                  25  


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  single domain antibody FR2

<400>  2

Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Phe Val Ser 
1               5                   10                  15      


Ala Ile Ser 
            


<210>  3
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  single domain antibody FR3

<400>  3

Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
1               5                   10                  15      


Ser Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            20                  25                  30          


Thr Ala Thr Tyr Tyr Cys Ala 
        35                  


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  single domain antibody FR4

<400>  4

Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser 
1               5                   10          


